Core Viewpoint - The capital is not abandoning the pet industry but is becoming more selective, focusing on key segments within the industry that show potential for growth and innovation [1]. Group 1: Investment Trends - In 2023, there were 33 public financing events in the domestic pet industry, with 5 of them being billion-level financings, indicating strong interest in the sector [3]. - The pet medical and pharmaceutical sectors are the most favored, with over 13 financing events, highlighting a preference for companies with core technologies, particularly in vaccine and new drug development [3]. - The pet food sector shows uneven investment, with established brands receiving more attention than new entrants, reflecting a shift from "traffic competition" to "supply chain competition" [3]. Group 2: Industry Integration - The pet industry is experiencing accelerated consolidation, with 7 major mergers and acquisitions and the establishment of 5 industry funds, totaling over 2 billion [5]. - Companies like Yiyi Co. and New Hope Group are actively acquiring brands to enhance their product lines, while firms like New Ruipeng and Ruipu Biological are launching funds covering various segments [5]. Group 3: Changing Investment Focus - Capital is increasingly focused on companies with standardized services and resource barriers, moving from fragmented services to scaled and digital operations [4]. - Investment institutions are now prioritizing companies that possess core technologies, stable production capacity, and the ability to offer differentiated services, marking a departure from previous models that emphasized rapid scaling and quick profits [6].
33起融资、20亿基金…2025宠物行业真实投融资图鉴
Sou Hu Cai Jing·2025-12-24 02:07